Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?

Many bacteriophages are obligate killers of bacteria. That this property could be medically useful was first recognized over one hundred years ago, with 2021 being the 100-year anniversary of the first clinical phage therapy publication. Here we consider modern use of phages in clinical settings. Ou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Stephen T. Abedon, Katarzyna M. Danis-Wlodarczyk, Diana R. Alves
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/0b1036d02ab04e3fb3921a5501672852
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b1036d02ab04e3fb3921a5501672852
record_format dspace
spelling oai:doaj.org-article:0b1036d02ab04e3fb3921a55016728522021-11-25T18:39:47ZPhage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?10.3390/ph141111571424-8247https://doaj.org/article/0b1036d02ab04e3fb3921a55016728522021-11-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1157https://doaj.org/toc/1424-8247Many bacteriophages are obligate killers of bacteria. That this property could be medically useful was first recognized over one hundred years ago, with 2021 being the 100-year anniversary of the first clinical phage therapy publication. Here we consider modern use of phages in clinical settings. Our aim is to answer one question: do phages serve as effective anti-bacterial infection agents when used clinically? An important emphasis of our analyses is on whether phage therapy-associated anti-bacterial infection efficacy can be reasonably distinguished from that associated with often coadministered antibiotics. We find that about half of 70 human phage treatment reports—published in English thus far in the 2000s—are suggestive of phage-mediated anti-bacterial infection efficacy. Two of these are randomized, double-blinded, infection-treatment studies while 14 of those studies, in our opinion, provide superior evidence of a phage role in observed treatment successes. Roughly three-quarters of these potentially phage-mediated outcomes are based on microbiological as well as clinical results, with the rest based on clinical success. Since many of these phage treatments are of infections for which antibiotic therapy had not been successful, their collective effectiveness is suggestive of a valid utility in employing phages to treat otherwise difficult-to-cure bacterial infections.Stephen T. AbedonKatarzyna M. Danis-WlodarczykDiana R. AlvesMDPI AGarticlebacteriophage therapycase studyclinical studycombination therapycompassionate useexpanded accessMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1157, p 1157 (2021)
institution DOAJ
collection DOAJ
language EN
topic bacteriophage therapy
case study
clinical study
combination therapy
compassionate use
expanded access
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle bacteriophage therapy
case study
clinical study
combination therapy
compassionate use
expanded access
Medicine
R
Pharmacy and materia medica
RS1-441
Stephen T. Abedon
Katarzyna M. Danis-Wlodarczyk
Diana R. Alves
Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
description Many bacteriophages are obligate killers of bacteria. That this property could be medically useful was first recognized over one hundred years ago, with 2021 being the 100-year anniversary of the first clinical phage therapy publication. Here we consider modern use of phages in clinical settings. Our aim is to answer one question: do phages serve as effective anti-bacterial infection agents when used clinically? An important emphasis of our analyses is on whether phage therapy-associated anti-bacterial infection efficacy can be reasonably distinguished from that associated with often coadministered antibiotics. We find that about half of 70 human phage treatment reports—published in English thus far in the 2000s—are suggestive of phage-mediated anti-bacterial infection efficacy. Two of these are randomized, double-blinded, infection-treatment studies while 14 of those studies, in our opinion, provide superior evidence of a phage role in observed treatment successes. Roughly three-quarters of these potentially phage-mediated outcomes are based on microbiological as well as clinical results, with the rest based on clinical success. Since many of these phage treatments are of infections for which antibiotic therapy had not been successful, their collective effectiveness is suggestive of a valid utility in employing phages to treat otherwise difficult-to-cure bacterial infections.
format article
author Stephen T. Abedon
Katarzyna M. Danis-Wlodarczyk
Diana R. Alves
author_facet Stephen T. Abedon
Katarzyna M. Danis-Wlodarczyk
Diana R. Alves
author_sort Stephen T. Abedon
title Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
title_short Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
title_full Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
title_fullStr Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
title_full_unstemmed Phage Therapy in the 21st Century: Is There Modern, Clinical Evidence of Phage-Mediated Efficacy?
title_sort phage therapy in the 21st century: is there modern, clinical evidence of phage-mediated efficacy?
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/0b1036d02ab04e3fb3921a5501672852
work_keys_str_mv AT stephentabedon phagetherapyinthe21stcenturyistheremodernclinicalevidenceofphagemediatedefficacy
AT katarzynamdaniswlodarczyk phagetherapyinthe21stcenturyistheremodernclinicalevidenceofphagemediatedefficacy
AT dianaralves phagetherapyinthe21stcenturyistheremodernclinicalevidenceofphagemediatedefficacy
_version_ 1718410814339153920